Home/Recalls/CANADA-64457
Health CanadaGeneral Alert

Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter

Published: August 9, 2022Recall ID: 64457Category: generalCountry: Canada
Canada
Safety AlertHealth CanadaCanadaCanada

Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter

Recalling Firm: Communications and Public Affairs Branch

Reason for Recall / Hazard

Product quality

Product Description & Identification

Check your product or contact your pharmacist to determine if it is affected. If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal.If you have used the recalled product and have health concerns, contact your healthcare provider. Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.Contact Taro Pharmaceuticals Inc. by calling toll free at 1-800-268-1975 if you have questions about this recall.Report any health product adverse events or complaints to Health Canada.

Affected Products

Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100)

Additional Source Details

FieldValue
N I D64457
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/taro-zoledronic-acid-injection-drug-used-osteoporosis-and-page-s-disease-recalled
IssueProduct quality
TitleTaro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter
ProductTaro-Zoledronic acid injection 5mg/100mL (DIN 02415100)
Archived0
CategoryDrugs
Last updated2022-08-09
OrganizationCommunications and Public Affairs Branch
What you should doCheck your product or contact your pharmacist to determine if it is affected. If you have a recalled product, do not use it and return it to your pharmacy for a replacement product and proper disposal.If you have used the recalled product and have health concerns, contact your healthcare provider. Go to the hospital immediately if you develop difficulty breathing, chest pain or confusion.Contact Taro Pharmaceuticals Inc. by calling toll free at 1-800-268-1975 if you have questions about this recall.Report any health product adverse events or complaints to Health Canada.

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Recall Hazard Severity
Caution (Class III)
Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Communications and Public Affairs Branch - Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter

Check if your household is affected:
https://therecallfile.com/recalls/taro-zoledronic-acid-injection-drug-used-for-osteoporosis-and-page-s-d/CANADA-64457
WhatsAppFacebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

The Recall File - The Google for Product Recalls | Product Hunt

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Donate with PayPal

Supports USD, EUR, GBP, International Cards & PayPal

Spread the WordTaro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter

Install The Recall File App

Check safety warnings, scan your pantry, and monitor your vehicles directly from your home screen.